

Group 1 - The U.S. will impose a 39% tariff on goods imported from Switzerland starting August 7, making Switzerland one of the few countries facing such high tariffs, second only to Brazil, Laos, Myanmar, and Syria [1][2] - The announcement coincided with Switzerland's National Day on August 1, which has been described as a significant humiliation for the country [2] - The trade deficit between the U.S. and Switzerland has surged, reaching nearly $50 billion in the first five months of the year, ranking Switzerland as the fifth largest trade deficit partner of the U.S. [5] Group 2 - Swiss officials were caught off guard by the high tariffs, as they believed negotiations with U.S. representatives were progressing well, with Switzerland expressing confidence in reaching a trade agreement [3][9] - The Swiss economy is heavily reliant on foreign trade, with approximately 19% of its exports going to the U.S., making it the largest export market for Switzerland [9] - The Swiss pharmaceutical industry, which exports about 60% of its products to the U.S., is under scrutiny, as it has been suggested that it may have hindered negotiations with the U.S. [12] Group 3 - The Swiss stock market is expected to open lower following the tariff announcement, with major companies like Novartis, Roche, and Nestlé listed on the Swiss exchange [12] - Analysts predict that if the tariffs remain unchanged, Switzerland's GDP could decline by approximately 0.6 percentage points, with more severe impacts if pharmaceuticals are excluded from tariff exemptions [13]